Concurrently, it has been reported that TIM-3 blockade enhanced IFN-γ expression by CD8+ T-cells in a murine orthotopic mammary carcinoma model and reduced the population of MDSCs in head and neck squamous cell carcinoma (23, 24). This evidence concerns the gene HAVCR2 and head and neck squamous cell carcinoma.